Phase II multicentre trial of oral quisinostat, a histone deacetylase inhibitor, in patients with previously treated stage IB – IVA mycosis fungoides/Sézary syndrome

2016 ◽  
Vol 175 (1) ◽  
pp. 80-88 ◽  
Author(s):  
F. Child ◽  
P.L. Ortiz‐Romero ◽  
R. Alvarez ◽  
M. Bagot ◽  
R. Stadler ◽  
...  
Keyword(s):  
Histone Deacetylase ◽  
Mycosis Fungoides ◽  
Phase Ii ◽  
Histone Deacetylase Inhibitor ◽  
Multicentre Trial ◽  
Sézary Syndrome ◽  
Sezary Syndrome ◽  
Stage Ib ◽  
Deacetylase Inhibitor ◽  
Previously Treated

scholarly journals The Therapeutic Potential of AN-7, a Novel Histone Deacetylase Inhibitor, for Treatment of Mycosis Fungoides/Sezary Syndrome Alone or with Doxorubicin

PLoS ONE ◽  
2016 ◽  
Vol 11 (1) ◽  
pp. e0146115 ◽  
Author(s):  
Lilach Moyal ◽  
Nataly Feldbaum ◽  
Neta Goldfeiz ◽  
Ada Rephaeli ◽  
Abraham Nudelman ◽  
...  
Keyword(s):  
Histone Deacetylase ◽  
Mycosis Fungoides ◽  
Histone Deacetylase Inhibitor ◽  
Therapeutic Potential ◽  
Sézary Syndrome ◽  
Sezary Syndrome ◽  
Deacetylase Inhibitor

Sézary syndrome managed with histone deacetylase inhibitor followed by anti-CCR4 monoclonal antibody

2018 ◽  
Vol 43 (3) ◽  
pp. 281-285 ◽  
Author(s):  
T. Numata ◽  
T. Nagatani ◽  
K. Shirai ◽  
T. Maeda ◽  
K. Mae ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Histone Deacetylase ◽  
Histone Deacetylase Inhibitor ◽  
Sézary Syndrome ◽  
Sezary Syndrome ◽  
Deacetylase Inhibitor

scholarly journals Phase II study of the histone deacetylase inhibitor MGCD0103 in patients with previously treated chronic lymphocytic leukaemia

2009 ◽  
Vol 147 (4) ◽  
pp. 507-514 ◽  
Author(s):  
Kristie A. Blum ◽  
Anjani Advani ◽  
Louis Fernandez ◽  
Richard Van Der Jagt ◽  
Joseph Brandwein ◽  
...  
Keyword(s):  
Chronic Lymphocytic Leukaemia ◽  
Histone Deacetylase ◽  
Phase Ii ◽  
Histone Deacetylase Inhibitor ◽  
Lymphocytic Leukaemia ◽  
Phase Ii Study ◽  
Deacetylase Inhibitor ◽  
Previously Treated

scholarly journals Phase II, two-stage, single-arm trial of the histone deacetylase inhibitor (HDACi) romidepsin in metastatic castration-resistant prostate cancer (CRPC)

2010 ◽  
Vol 21 (1) ◽  
pp. 109-113 ◽  
Author(s):  
L.R. Molife ◽  
G. Attard ◽  
P.C. Fong ◽  
V. Karavasilis ◽  
A.H.M. Reid ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Histone Deacetylase ◽  
Phase Ii ◽  
Histone Deacetylase Inhibitor ◽  
Castration Resistant Prostate Cancer ◽  
Two Stage ◽  
Castration Resistant ◽  
Deacetylase Inhibitor

scholarly journals Phase II trial of the histone deacetylase inhibitor romidepsin in patients with recurrent/metastatic head and neck cancer

Oral Oncology ◽  
2012 ◽  
Vol 48 (12) ◽  
pp. 1281-1288 ◽  
Author(s):  
Missak Haigentz ◽  
Mimi Kim ◽  
Catherine Sarta ◽  
Juan Lin ◽  
Roger S. Keresztes ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Histone Deacetylase ◽  
Phase Ii ◽  
Neck Cancer ◽  
Histone Deacetylase Inhibitor ◽  
Phase Ii Trial ◽  
Deacetylase Inhibitor

scholarly journals A phase II study of SB939, a novel pan-histone deacetylase inhibitor, in patients with translocation-associated recurrent/metastatic sarcomas—NCIC-CTG IND 200

2015 ◽  
Vol 26 (5) ◽  
pp. 973-981 ◽  
Author(s):  
Q. S.-C. Chu ◽  
T.O. Nielsen ◽  
T. Alcindor ◽  
A. Gupta ◽  
M. Endo ◽  
...  
Keyword(s):  
Histone Deacetylase ◽  
Phase Ii ◽  
Histone Deacetylase Inhibitor ◽  
Phase Ii Study ◽  
Deacetylase Inhibitor
Sign in / Sign up

Export Citation Format

Share Document